ERBB2 and breast cancer: In 2D, HER2‐depleted T47D breast cancer cells (−90% of HER2 protein expression, Fig. 1A, left down), showed reduced cell proliferation compared with nontransduced (control) and empty vector transduced cells (Fig. 1A, left up).